Free Trial Information
BioCentury | Nov 23, 2015
Financial News

ElMindA completes venture financing

...completed: 2015-11-16 Type: Venture financing Raised: $28 million Investors: Shanda Group; Kraft Group; Wexford Capital; WR Hambrecht + Co....
Read More
BioCentury | May 16, 2011
Finance

Banker Tracks

Banker tracks Joe Ruggieri joined ISI Group as a managing director focused on healthcare trading. He was a managing director at Wells Fargo. Sean Cessna joined JMP Securities as a director in the healthcare investment...
Read More
BioCentury | Oct 26, 2009
Finance

Ebb & Flow

...wide open window for conventional IPOs, Burrill & Co. has formed a joint venture with WR Hambrecht + Co....
Read More
BioCentury | Apr 4, 2005
Finance

Ebb & Flow

TolerRx has been quietly busy since it pulled its IPO last summer. After hitting a series of milestones, the company last week announced a $30 million series D round. President and CEO Douglas Ringler said...
Read More
Items per page:
1 - 4 of 4
BioCentury | Nov 23, 2015
Financial News

ElMindA completes venture financing

...completed: 2015-11-16 Type: Venture financing Raised: $28 million Investors: Shanda Group; Kraft Group; Wexford Capital; WR Hambrecht + Co....
Read More
BioCentury | May 16, 2011
Finance

Banker Tracks

Banker tracks Joe Ruggieri joined ISI Group as a managing director focused on healthcare trading. He was a managing director at Wells Fargo. Sean Cessna joined JMP Securities as a director in the healthcare investment...
Read More
BioCentury | Oct 26, 2009
Finance

Ebb & Flow

...wide open window for conventional IPOs, Burrill & Co. has formed a joint venture with WR Hambrecht + Co....
Read More
BioCentury | Apr 4, 2005
Finance

Ebb & Flow

TolerRx has been quietly busy since it pulled its IPO last summer. After hitting a series of milestones, the company last week announced a $30 million series D round. President and CEO Douglas Ringler said...
Read More
Items per page:
1 - 4 of 4